177 related articles for article (PubMed ID: 33793647)
1. Human osteoclastogenesis in Epstein-Barr virus-induced erosive arthritis in humanized NOD/Shi-scid/IL-2Rγnull mice.
Nagasawa Y; Takei M; Iwata M; Nagatsuka Y; Tsuzuki H; Imai K; Imadome KI; Fujiwara S; Kitamura N
PLoS One; 2021; 16(4):e0249340. PubMed ID: 33793647
[TBL] [Abstract][Full Text] [Related]
2. Epstein-barr virus infections induce aberrant osteoclastogenesis in immune system-humanized NOD/Shi-scid/IL-2RγC
Nagatsuka Y; Iwata M; Nagasawa Y; Tsuzuki H; Kitamura N; Komatsu A; Kawana K; Ito R; Fujiwara S; Nakamura H; Takei M
Biochem Biophys Res Commun; 2024 Jun; 715():149984. PubMed ID: 38688056
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus induces erosive arthritis in humanized mice.
Kuwana Y; Takei M; Yajima M; Imadome K; Inomata H; Shiozaki M; Ikumi N; Nozaki T; Shiraiwa H; Kitamura N; Takeuchi J; Sawada S; Yamamoto N; Shimizu N; Ito M; Fujiwara S
PLoS One; 2011; 6(10):e26630. PubMed ID: 22028930
[TBL] [Abstract][Full Text] [Related]
4. Assessment of benzene-induced hematotoxicity using a human-like hematopoietic lineage in NOD/Shi-scid/IL-2Rγnull mice.
Takahashi M; Tsujimura N; Yoshino T; Hosokawa M; Otsuka K; Matsunaga T; Nakasono S
PLoS One; 2012; 7(12):e50448. PubMed ID: 23226520
[TBL] [Abstract][Full Text] [Related]
5. Excavatolide B Attenuates Rheumatoid Arthritis through the Inhibition of Osteoclastogenesis.
Lin YY; Jean YH; Lee HP; Lin SC; Pan CY; Chen WF; Wu SF; Su JH; Tsui KH; Sheu JH; Sung PJ; Wen ZH
Mar Drugs; 2017 Jan; 15(1):. PubMed ID: 28067799
[TBL] [Abstract][Full Text] [Related]
6. Ferulic acid, a dietary polyphenol suppresses osteoclast differentiation and bone erosion via the inhibition of RANKL dependent NF-κB signalling pathway.
Doss HM; Samarpita S; Ganesan R; Rasool M
Life Sci; 2018 Aug; 207():284-295. PubMed ID: 29908722
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-17A induces cathepsin K and MMP-9 expression in osteoclasts via celecoxib-blocked prostaglandin E2 in osteoblasts.
Zhang F; Tanaka H; Kawato T; Kitami S; Nakai K; Motohashi M; Suzuki N; Wang CL; Ochiai K; Isokawa K; Maeno M
Biochimie; 2011 Feb; 93(2):296-305. PubMed ID: 20937352
[TBL] [Abstract][Full Text] [Related]
8. Intravenously delivered glucocorticoid liposomes inhibit osteoclast activity and bone erosion in murine antigen-induced arthritis.
Hofkens W; Grevers LC; Walgreen B; de Vries TJ; Leenen PJ; Everts V; Storm G; van den Berg WB; van Lent PL
J Control Release; 2011 Jun; 152(3):363-9. PubMed ID: 21396411
[TBL] [Abstract][Full Text] [Related]
9. Oleanolic acid exerts inhibitory effects on the late stage of osteoclastogenesis and prevents bone loss in osteoprotegerin knockout mice.
Zhao D; Shu B; Wang C; Zhao Y; Cheng W; Sha N; Li C; Wang Q; Lu S; Wang Y
J Cell Biochem; 2020 Jan; 121(1):152-164. PubMed ID: 31318102
[TBL] [Abstract][Full Text] [Related]
10. Autophagy-linked FYVE containing protein WDFY3 interacts with TRAF6 and modulates RANKL-induced osteoclastogenesis.
Wu DJ; Gu R; Sarin R; Zavodovskaya R; Chen CP; Christiansen BA; Zarbalis KS; Adamopoulos IE
J Autoimmun; 2016 Sep; 73():73-84. PubMed ID: 27330028
[TBL] [Abstract][Full Text] [Related]
11. Augmented LPS responsiveness in type 1 diabetes-derived osteoclasts.
Catalfamo DL; Calderon NL; Harden SW; Sorenson HL; Neiva KG; Wallet SM
J Cell Physiol; 2013 Feb; 228(2):349-61. PubMed ID: 22718269
[TBL] [Abstract][Full Text] [Related]
12. Cathepsin K deficiency partially inhibits, but does not prevent, bone destruction in human tumor necrosis factor-transgenic mice.
Schurigt U; Hummel KM; Petrow PK; Gajda M; Stöckigt R; Middel P; Zwerina J; Janik T; Bernhardt R; Schüler S; Scharnweber D; Beckmann F; Saftig P; Kollias G; Schett G; Wiederanders B; Bräuer R
Arthritis Rheum; 2008 Feb; 58(2):422-34. PubMed ID: 18240253
[TBL] [Abstract][Full Text] [Related]
13. Effect of interleukin-6 secreted by engineered human stromal cells on osteoclasts in human bone.
Sandhu JS; Gorczynski RM; Waddell J; Nguyen H; Squires J; Waddell J; Boynton EL; Hozumi N
Bone; 1999 Mar; 24(3):217-27. PubMed ID: 10071914
[TBL] [Abstract][Full Text] [Related]
14. Kalkitoxin Reduces Osteoclast Formation and Resorption and Protects against Inflammatory Bone Loss.
Li L; Yang M; Shrestha SK; Kim H; Gerwick WH; Soh Y
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669069
[TBL] [Abstract][Full Text] [Related]
15. Murine Models of Epstein-Barr Virus-Associated Lymphomagenesis.
Ahmed EH; Baiocchi RA
ILAR J; 2016; 57(1):55-62. PubMed ID: 27034395
[TBL] [Abstract][Full Text] [Related]
16. The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice).
Watanabe Y; Takahashi T; Okajima A; Shiokawa M; Ishii N; Katano I; Ito R; Ito M; Minegishi M; Minegishi N; Tsuchiya S; Sugamura K
Int Immunol; 2009 Jul; 21(7):843-58. PubMed ID: 19515798
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of osteoclast differentiation and collagen antibody-induced arthritis by CTHRC1.
Jin YR; Stohn JP; Wang Q; Nagano K; Baron R; Bouxsein ML; Rosen CJ; Adarichev VA; Lindner V
Bone; 2017 Apr; 97():153-167. PubMed ID: 28115279
[TBL] [Abstract][Full Text] [Related]
18. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor.
Gravallese EM; Manning C; Tsay A; Naito A; Pan C; Amento E; Goldring SR
Arthritis Rheum; 2000 Feb; 43(2):250-8. PubMed ID: 10693863
[TBL] [Abstract][Full Text] [Related]
19. Increased Granulopoiesis in the Bone Marrow following Epstein-Barr Virus Infection.
Katahira Y; Higuchi H; Matsushita H; Yahata T; Yamamoto Y; Koike R; Ando K; Sato K; Imadome KI; Kotani A
Sci Rep; 2019 Sep; 9(1):13445. PubMed ID: 31530932
[TBL] [Abstract][Full Text] [Related]
20. Technetium-99 conjugated with methylene diphosphonate inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis.
Gong W; Dou H; Liu X; Sun L; Hou Y
Clin Exp Pharmacol Physiol; 2012 Oct; 39(10):886-93. PubMed ID: 23013134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
